BlackRock Discloses 9.4% Stake in Lemaitre Vascular
Ticker: LMAT · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still holds a big chunk of LMAT, signaling continued institutional interest.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, disclosing its ownership of 2,017,890 shares of Lemaitre Vascular Inc. common stock as of December 31, 2023. This represents a 9.4% beneficial ownership stake in the company. This filing is important for investors because it shows that a major institutional investor like BlackRock maintains a significant, though slightly reduced, position in Lemaitre Vascular, indicating continued confidence in the company's long-term prospects.
Why It Matters
This filing shows a major institutional investor's current stake, which can influence market perception and investor confidence in Lemaitre Vascular Inc.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and does not indicate any immediate significant risk to the company or its stock.
Analyst Insight
Investors should note that a large institutional holder like BlackRock maintains a substantial position, which can be a sign of long-term confidence, but this filing itself doesn't suggest immediate buying or selling action.
Key Numbers
- 2,017,890 — Shares Beneficially Owned (BlackRock's total shares in Lemaitre Vascular Inc.)
- 9.4% — Percentage of Class (BlackRock's ownership stake in Lemaitre Vascular Inc.)
- December 31, 2023 — Reporting Date (The date as of which the ownership was calculated.)
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Lemaitre Vascular Inc. (company) — the subject company whose shares are being reported
- 2,017,890 (dollar_amount) — number of shares beneficially owned by BlackRock Inc.
- 9.4% (dollar_amount) — percentage of class beneficially owned by BlackRock Inc.
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- BlackRock will likely maintain a significant, but passive, stake in Lemaitre Vascular Inc. throughout 2024. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment by BlackRock Inc. to update its beneficial ownership stake in Lemaitre Vascular Inc. as of December 31, 2023, under Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., a major institutional investment manager based at 50 Hudson Yards, New York, NY.
What percentage of Lemaitre Vascular Inc. common stock does BlackRock Inc. beneficially own?
As of December 31, 2023, BlackRock Inc. beneficially owns 9.4% of the common stock of Lemaitre Vascular Inc.
How many shares of Lemaitre Vascular Inc. common stock does BlackRock Inc. beneficially own?
BlackRock Inc. beneficially owns 2,017,890 shares of Lemaitre Vascular Inc. common stock.
When was the event date that triggered this filing?
The event date which required the filing of this statement was December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding LEMAITRE VASCULAR INC (LMAT).